SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-19-003889
Filing Date
2019-01-07
Accepted
2019-01-07 17:09:03
Documents
9

Document Format Files

Seq Description Document Type Size
1 SC14D9C d685544dsc14d9c.htm SC14D9C 20091
2 EX-99.1 d685544dex991.htm EX-99.1 10346
3 EX-99.2 d685544dex992.htm EX-99.2 21908
4 EX-99.3 d685544dex993.htm EX-99.3 9484
5 EX-99.4 d685544dex994.htm EX-99.4 6900
6 EX-99.5 d685544dex995.htm EX-99.5 7287
7 EX-99.6 d685544dex996.htm EX-99.6 7684
8 EX-99.7 d685544dex997.htm EX-99.7 7789
9 EX-99.8 d685544dex998.htm EX-99.8 7735
  Complete submission text file 0001193125-19-003889.txt   100764
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filed by) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Subject) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-88267 | Film No.: 19513980
SIC: 2834 Pharmaceutical Preparations